APO RESEARCH · REPORT
Artificial Pancreas Devices Systems
The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Product & engineering
Understand the product.
The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
Selected research
Industry Growth & Trends
Global Artificial Pancreas Devices Systems Industry Growth and Trends Forecast to 2032
Market perspective
The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."
Read the full market overview
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
Medtronic monopolizes the global Artificial Pancreas Devices Systems market, holding a share about 100%.
North America is the largest market, with a share about 60%, followed by Europe, have a share about 30 percent.
In terms of product, Threshold Suspended Device Systems is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospitals
, followed by Clinics.
Report Scope
This report provides a structured, data-driven view of the global Artificial Pancreas Devices Systems market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Artificial Pancreas Devices Systems market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Artificial Pancreas Devices Systems market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Artificial Pancreas Devices Systems.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Artificial Pancreas Devices Systems market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Artificial Pancreas Devices Systems Market by Company
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed
Artificial Pancreas Devices Systems Segment by Type
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other Systems
Artificial Pancreas Devices Systems Segment by Application
Hospitals
Clinics
Artificial Pancreas Devices Systems Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Pancreas Devices Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artificial Pancreas Devices Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Pancreas Devices Systems.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Pancreas Devices Systems manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Artificial Pancreas Devices Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Threshold Suspended Device Systems
- Hybrid Closed-loop APDS
- Other Systems
Applications
- Hospitals
- Clinics
Companies covered
- Medtronic
- Bigfoot Biomedical
- Beta Bionics
- Admetsys
- Insulet
- Tandem Diabetes Care
- Defymed
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Artificial Pancreas Devices Systems Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Artificial Pancreas Devices Systems Sales Estimates and Forecasts (2021-2032)
- 1.3 Artificial Pancreas Devices Systems Market by Type
- 1.3.1 Threshold Suspended Device Systems
- 1.3.2 Hybrid Closed-loop APDS
- 1.3.3 Other Systems
- 1.4 Global Artificial Pancreas Devices Systems Market Size by Type
- 1.4.1 Global Artificial Pancreas Devices Systems Market Size Overview by Type (2021-2032)
- 1.4.2 Global Artificial Pancreas Devices Systems Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Artificial Pancreas Devices Systems Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Artificial Pancreas Devices Systems Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Artificial Pancreas Devices Systems Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Artificial Pancreas Devices Systems Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Artificial Pancreas Devices Systems Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Artificial Pancreas Devices Systems Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Artificial Pancreas Devices Systems Industry Trends
- 2.2 Artificial Pancreas Devices Systems Industry Drivers
- 2.3 Artificial Pancreas Devices Systems Industry Opportunities and Challenges
- 2.4 Artificial Pancreas Devices Systems Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Artificial Pancreas Devices Systems Revenue (2021-2026)
- 3.2 Global Top Players by Artificial Pancreas Devices Systems Sales (2021-2026)
- 3.3 Global Top Players by Artificial Pancreas Devices Systems Price (2021-2026)
- 3.4 Global Artificial Pancreas Devices Systems Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Artificial Pancreas Devices Systems Major Company Production Sites & Headquarters
- 3.6 Global Artificial Pancreas Devices Systems Company, Product Type & Application
- 3.7 Global Artificial Pancreas Devices Systems Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Artificial Pancreas Devices Systems Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Artificial Pancreas Devices Systems Players Market Share by Revenue in 2025
- 3.8.3 2025 Artificial Pancreas Devices Systems Tier 1, Tier 2, and Tier 3
4 Artificial Pancreas Devices Systems Regional Status and Outlook
- 4.1 Global Artificial Pancreas Devices Systems Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Artificial Pancreas Devices Systems Historic Market Size by Region
- 4.2.1 Global Artificial Pancreas Devices Systems Sales in Volume by Region (2021-2026)
- 4.2.2 Global Artificial Pancreas Devices Systems Sales in Value by Region (2021-2026)
- 4.2.3 Global Artificial Pancreas Devices Systems Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Artificial Pancreas Devices Systems Forecasted Market Size by Region
- 4.3.1 Global Artificial Pancreas Devices Systems Sales in Volume by Region (2027-2032)
- 4.3.2 Global Artificial Pancreas Devices Systems Sales in Value by Region (2027-2032)
- 4.3.3 Global Artificial Pancreas Devices Systems Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Artificial Pancreas Devices Systems by Application
- 5.1 Artificial Pancreas Devices Systems Market by Application
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.2 Global Artificial Pancreas Devices Systems Market Size by Application
- 5.2.1 Global Artificial Pancreas Devices Systems Market Size Overview by Application (2021-2032)
- 5.2.2 Global Artificial Pancreas Devices Systems Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Artificial Pancreas Devices Systems Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Artificial Pancreas Devices Systems Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Artificial Pancreas Devices Systems Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Artificial Pancreas Devices Systems Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Artificial Pancreas Devices Systems Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Artificial Pancreas Devices Systems Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Medtronic
- 6.1.1 Medtronic Company Information
- 6.1.2 Medtronic Business Overview
- 6.1.3 Medtronic Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Medtronic Artificial Pancreas Devices Systems Product Portfolio
- 6.1.5 Medtronic Recent Developments
- 6.2 Bigfoot Biomedical
- 6.2.1 Bigfoot Biomedical Company Information
- 6.2.2 Bigfoot Biomedical Business Overview
- 6.2.3 Bigfoot Biomedical Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Bigfoot Biomedical Artificial Pancreas Devices Systems Product Portfolio
- 6.2.5 Bigfoot Biomedical Recent Developments
- 6.3 Beta Bionics
- 6.3.1 Beta Bionics Company Information
- 6.3.2 Beta Bionics Business Overview
- 6.3.3 Beta Bionics Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Beta Bionics Artificial Pancreas Devices Systems Product Portfolio
- 6.3.5 Beta Bionics Recent Developments
- 6.4 Admetsys
- 6.4.1 Admetsys Company Information
- 6.4.2 Admetsys Business Overview
- 6.4.3 Admetsys Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Admetsys Artificial Pancreas Devices Systems Product Portfolio
- 6.4.5 Admetsys Recent Developments
- 6.5 Insulet
- 6.5.1 Insulet Company Information
- 6.5.2 Insulet Business Overview
- 6.5.3 Insulet Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Insulet Artificial Pancreas Devices Systems Product Portfolio
- 6.5.5 Insulet Recent Developments
- 6.6 Tandem Diabetes Care
- 6.6.1 Tandem Diabetes Care Company Information
- 6.6.2 Tandem Diabetes Care Business Overview
- 6.6.3 Tandem Diabetes Care Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Tandem Diabetes Care Artificial Pancreas Devices Systems Product Portfolio
- 6.6.5 Tandem Diabetes Care Recent Developments
- 6.7 Defymed
- 6.7.1 Defymed Company Information
- 6.7.2 Defymed Business Overview
- 6.7.3 Defymed Artificial Pancreas Devices Systems Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Defymed Artificial Pancreas Devices Systems Product Portfolio
- 6.7.5 Defymed Recent Developments
7 North America by Country
- 7.1 North America Artificial Pancreas Devices Systems Sales by Country
- 7.1.1 North America Artificial Pancreas Devices Systems Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Artificial Pancreas Devices Systems Sales by Country (2021-2026)
- 7.1.3 North America Artificial Pancreas Devices Systems Sales Forecast by Country (2027-2032)
- 7.2 North America Artificial Pancreas Devices Systems Market Size by Country
- 7.2.1 North America Artificial Pancreas Devices Systems Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Artificial Pancreas Devices Systems Market Size by Country (2021-2026)
- 7.2.3 North America Artificial Pancreas Devices Systems Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Artificial Pancreas Devices Systems Sales by Country
- 8.1.1 Europe Artificial Pancreas Devices Systems Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Artificial Pancreas Devices Systems Sales by Country (2021-2026)
- 8.1.3 Europe Artificial Pancreas Devices Systems Sales Forecast by Country (2027-2032)
- 8.2 Europe Artificial Pancreas Devices Systems Market Size by Country
- 8.2.1 Europe Artificial Pancreas Devices Systems Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Artificial Pancreas Devices Systems Market Size by Country (2021-2026)
- 8.2.3 Europe Artificial Pancreas Devices Systems Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Artificial Pancreas Devices Systems Sales by Country
- 9.1.1 Asia-Pacific Artificial Pancreas Devices Systems Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Artificial Pancreas Devices Systems Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Artificial Pancreas Devices Systems Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Artificial Pancreas Devices Systems Market Size by Country
- 9.2.1 Asia-Pacific Artificial Pancreas Devices Systems Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Artificial Pancreas Devices Systems Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Artificial Pancreas Devices Systems Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Artificial Pancreas Devices Systems Sales by Country
- 10.1.1 South America Artificial Pancreas Devices Systems Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Artificial Pancreas Devices Systems Sales by Country (2021-2026)
- 10.1.3 South America Artificial Pancreas Devices Systems Sales Forecast by Country (2027-2032)
- 10.2 South America Artificial Pancreas Devices Systems Market Size by Country
- 10.2.1 South America Artificial Pancreas Devices Systems Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Artificial Pancreas Devices Systems Market Size by Country (2021-2026)
- 10.2.3 South America Artificial Pancreas Devices Systems Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Artificial Pancreas Devices Systems Sales by Country
- 11.1.1 Middle East and Africa Artificial Pancreas Devices Systems Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Artificial Pancreas Devices Systems Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Artificial Pancreas Devices Systems Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Artificial Pancreas Devices Systems Market Size by Country
- 11.2.1 Middle East and Africa Artificial Pancreas Devices Systems Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Artificial Pancreas Devices Systems Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Artificial Pancreas Devices Systems Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Artificial Pancreas Devices Systems Value Chain Analysis
- 12.1.1 Artificial Pancreas Devices Systems Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Artificial Pancreas Devices Systems Production Mode & Process
- 12.2 Artificial Pancreas Devices Systems Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Artificial Pancreas Devices Systems Distributors
- 12.2.3 Artificial Pancreas Devices Systems Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst